Question · asked by 1 review

Naloxone + oxycodone prolonged release tablets vs oxycodone: Serious adverse eventsg

Population
people with cancer irrespective of whether they were receiving palliative care opioid‐induced bowel dysfunction
Intervention
Naloxone + oxycodone prolonged release tablets
Comparison
oxycodone
Outcome
Serious adverse eventsg

It is very uncertain whether naloxone + oxycodone prolonged release tablets changes serious adverse eventsg compared with oxycodone prolonged‐released tablets (very low certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Naloxone + oxycodone prolonged release tablets vs oxycodone prolonged‐released tablets
Serious adverse eventsg · people with cancer irrespective of whether they were receiving palliative care opioid‐induced bowel dysfunction
It is very uncertain whether naloxone + oxycodone prolonged release tablets changes serious adverse eventsg compared with oxycodone prolonged‐released tablets (very low certainty).
Mu‐opioid antagonists for opioid‐induced bowel dysfunction in people with cancer and people receiving… (2022) · Cochrane Headline outcomes only
RR 0.68 [0.44, 1.06]3 studies · 362 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Mu‐opioid antagonists for opioid‐induced bowel dysfunction in people with cancer and people receiving palliative care
2022 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed
How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.